Target Tacrolimus Levels in Liver Transplant Patients

Introduction to Tacrolimus Target Levels

The European Association for the Study of the Liver (EASL) guidelines recommend maintaining tacrolimus trough levels at 6-10 ng/ml during the first month post-transplant, then reducing to 4-8 ng/ml for long-term maintenance on monotherapy, as suggested by the Journal of Hepatology 1

The EASL guidelines (2024) recommend tacrolimus trough levels of 6-10 ng/ml for monotherapy during the initial high-risk period for rejection 1

Beyond the first year, most patients can be maintained on 4-6 ng/ml with tacrolimus monotherapy, according to the Journal of Hepatology 1
The American Society of Transplantation, as reported by the American Journal of Transplantation, recommends levels around 5 ng/ml after one year 3

When tacrolimus is combined with basiliximab induction and/or additional immunosuppressants, use lower trough levels than monotherapy to preserve renal function, as recommended by the Journal of Hepatology 1
For patients at risk of post-transplant renal dysfunction, consider basiliximab with MMF or AZA to allow a 5-day delay in tacrolimus introduction, as suggested by the Journal of Hepatology 1

Measure trough levels daily until the target is reached, then monitor every 2-3 days until hospital discharge, as recommended by the guideline society 4

Screen for preformed donor-specific antibodies (DSAs) in patients with previous transplantation, transfusions, or pregnancies, and monitor for de novo DSAs in combination with ALT and transient elastography to identify subclinical rejection risk, as recommended by the Journal of Hepatology 1
Minimize CNI exposure by employing combined immunosuppressive regimens, preferably mTORi-based, in patients with high risk of hepatic or extrahepatic cancer recurrence, according to the Journal of Hepatology 1

Exercise caution when switching formulations, as this may precipitate rejection episodes; increase monitoring frequency with any formulation change, as recommended by the American Society of Transplantation, as reported by the American Journal of Transplantation 3